Literature DB >> 17885205

The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics.

Emilie Ceraudo1, Samuel Murail, Yossan-Var Tan, Jean-Jacques Lacapère, Jean-Michel Neumann, Alain Couvineau, Marc Laburthe.   

Abstract

The neuropeptide vasoactive intestinal peptide (VIP) strongly impacts on human pathophysiology and does so through interaction with class II G protein-coupled receptors. We characterized the C terminus-binding site of VIP in the N-terminal ectodomain (N-ted) of the human VPAC1 receptor: 1) The probe [(125)I-Bpa(28)]VIP in which the C-terminal residue (Asn(28)) is substituted by a photoreactive p-benzoyl-l-Phe (Bpa) was used to photolabel the receptor. After receptor cleavage and Edman sequencing, it was shown that Asn(28) of VIP is in contact with Lys(127) in the receptor N-ted. Taking into account previous data, it follows that the C-terminal and central parts of VIP from Asn(28) to Phe(6) lie in the N-ted. 2) A three-dimensional model of the N-ted was constructed, the fold being identified as a Sushi domain with two antiparallel beta-sheets and three disulfide bonds. The nuclear magnetic resonance structure of VIP was then docked into this model by taking into account the constraint provided by photoaffinity experiments with [(125)I-Bpa(28)]VIP. It appeared that VIP runs parallel to the beta3-beta4 antiparallel sheets. 3) We performed molecular dynamic simulations over 14 nsec of the complex between VIP and receptor N-ted and the free N-ted. The structural model of the free N-ted is stable, and VIP tends to further stabilize the N-ted structure more especially in the loops connecting the beta-sheets. These structural studies provide a detailed molecular understanding of the VIP-receptor interaction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885205      PMCID: PMC5419634          DOI: 10.1210/me.2007-0361

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  30 in total

Review 1.  The significance of vasoactive intestinal peptide in immunomodulation.

Authors:  Mario Delgado; David Pozo; Doina Ganea
Journal:  Pharmacol Rev       Date:  2004-06       Impact factor: 25.468

Review 2.  Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors.

Authors:  Sam R J Hoare
Journal:  Drug Discov Today       Date:  2005-03-15       Impact factor: 7.851

3.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

4.  Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome.

Authors:  R Schwarzenbacher; K Zeth; K Diederichs; A Gries; G M Kostner; P Laggner; R Prassl
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

5.  The human VPAC1 receptor: three-dimensional model and mutagenesis of the N-terminal domain.

Authors:  L Lins; A Couvineau; C Rouyer-Fessard; P Nicole; J J Maoret; M Benhamed; R Brasseur; A Thomas; M Laburthe
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

6.  VPAC(1) receptors have different agonist efficacy profiles on membrane and intact cells.

Authors:  Ingrid Langer; Pascale Vertongen; Jason Perret; Johnny Cnudde; Françoise Gregoire; Philippe De Neef; Patrick Robberecht; Magali Waelbroeck
Journal:  Cell Signal       Date:  2002-08       Impact factor: 4.315

Review 7.  Pharmaceutical VIP: prospects and problems.

Authors:  I Gozes; M Fridkinb; J M Hill; D E Brenneman
Journal:  Curr Med Chem       Date:  1999-11       Impact factor: 4.530

8.  Identification of cytoplasmic domains of hVPAC1 receptor required for activation of adenylyl cyclase. Crucial role of two charged amino acids strictly conserved in class II G protein-coupled receptors.

Authors:  Alain Couvineau; Jean-Jacques Lacapere; Yossan-Var Tan; Christiane Rouyer-Fessard; Pascal Nicole; Marc Laburthe
Journal:  J Biol Chem       Date:  2003-04-10       Impact factor: 5.157

9.  Peptide agonist docking in the N-terminal ectodomain of a class II G protein-coupled receptor, the VPAC1 receptor. Photoaffinity, NMR, and molecular modeling.

Authors:  Yossan-Var Tan; Alain Couvineau; Samuel Murail; Emilie Ceraudo; Jean-Michel Neumann; Jean-Jacques Lacapère; Marc Laburthe
Journal:  J Biol Chem       Date:  2006-03-06       Impact factor: 5.157

10.  Photoaffinity labeling demonstrates physical contact between vasoactive intestinal peptide and the N-terminal ectodomain of the human VPAC1 receptor.

Authors:  Yossan-Var Tan; Alain Couvineau; Jean Van Rampelbergh; Marc Laburthe
Journal:  J Biol Chem       Date:  2003-06-13       Impact factor: 5.157

View more
  21 in total

1.  Characterization and use of a rabbit-anti-mouse VPAC1 antibody by flow cytometry.

Authors:  Rebecca J Hermann; Travis Van der Steen; Emilie E Vomhof-Dekrey; Sejaa Al-Badrani; Steve B Wanjara; Jarrett J Failing; Jodie S Haring; Glenn P Dorsam
Journal:  J Immunol Methods       Date:  2011-11-04       Impact factor: 2.303

Review 2.  VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins.

Authors:  Alain Couvineau; Marc Laburthe
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs.

Authors:  M Dong; C Koole; D Wootten; P M Sexton; L J Miller
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

4.  Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling.

Authors:  Laurence J Miller; Quan Chen; Polo C-H Lam; Delia I Pinon; Patrick M Sexton; Ruben Abagyan; Maoqing Dong
Journal:  J Biol Chem       Date:  2011-03-16       Impact factor: 5.157

5.  Spatial approximations between residues 6 and 12 in the amino-terminal region of glucagon-like peptide 1 and its receptor: a region critical for biological activity.

Authors:  Quan Chen; Delia I Pinon; Laurence J Miller; Maoqing Dong
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

Review 6.  Insights into the structure of class B GPCRs.

Authors:  Kaspar Hollenstein; Chris de Graaf; Andrea Bortolato; Ming-Wei Wang; Fiona H Marshall; Raymond C Stevens
Journal:  Trends Pharmacol Sci       Date:  2013-12-18       Impact factor: 14.819

7.  Vasoactive intestinal peptide signaling axis in human leukemia.

Authors:  Glenn Paul Dorsam; Keith Benton; Jarrett Failing; Sandeep Batra
Journal:  World J Biol Chem       Date:  2011-06-26

Review 8.  Conformational switches in the VPAC(1) receptor.

Authors:  Ingrid Langer
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

9.  Crucial role of the orexin-B C-terminus in the induction of OX1 receptor-mediated apoptosis: analysis by alanine scanning, molecular modelling and site-directed mutagenesis.

Authors:  Pascal Nicole; Pierre Couvineau; Nadege Jamin; Thierry Voisin; Alain Couvineau
Journal:  Br J Pharmacol       Date:  2015-09-30       Impact factor: 8.739

10.  Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis.

Authors:  Varun Sethi; Israel Rubinstein; Antonina Kuzmis; Helen Kastrissios; James Artwohl; Hayat Onyuksel
Journal:  Mol Pharm       Date:  2013-01-23       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.